Denosumab Treatment: Uses, Dosing, and Side Effects Explained

Summary of Key Points

Denosumab is a prescription medication used to treat various bone-related conditions, including osteoporosis and bone metastases. It works by slowing down bone breakdown, strengthening bones, and reducing the risk of fractures. Denosumab is typically administered via injection and is often prescribed for patients who cannot tolerate other treatments. Always consult your healthcare provider before starting or adjusting your dose.

Names of Medication

US Brand Names: Prolia, Xgeva (Denosumab)

The generic name refers to the active ingredient, while the brand name is the commercial name under which the drug is sold. The generic name is listed in parentheses.

Pharmacologic Category

RANK Ligand Inhibitor

Denosumab Dosing Schedule

Denosumab is used to treat several conditions. Below are the recommended doses for each condition. Always consult your healthcare provider before adjusting your dose. If you need to speak with a provider, you can schedule a telemedicine appointment with one of our doctors today.

1. Osteoporosis (in postmenopausal women and men): 60 mg subcutaneously every 6 months.
2. Bone Metastases (from solid tumors): 120 mg subcutaneously every 4 weeks.
3. Giant Cell Tumor of Bone: 120 mg subcutaneously every 4 weeks, with additional doses on days 8 and 15 during the first month of therapy.
4. Hypercalcemia of Malignancy: 120 mg subcutaneously every 4 weeks, with additional doses on days 8 and 15 during the first month of therapy.
5. Paget’s Disease of Bone: Not FDA-approved for this indication, but consult your doctor for off-label use.
6. Multiple Myeloma: 120 mg subcutaneously every 4 weeks.
7. Osteogenesis Imperfecta: Not FDA-approved for this indication, but consult your doctor for off-label use.
8. Osteopenia: 60 mg subcutaneously every 6 months.
9. Rheumatoid Arthritis: 60 mg subcutaneously every 6 months.
10. Osteolytic Lesions: 120 mg subcutaneously every 4 weeks.

Dosage Forms and Strengths

Denosumab is available in the following forms:

1. Denosumab 60 mg/mL solution for subcutaneous injection (Prolia)
2. Denosumab 120 mg/1.7 mL solution for subcutaneous injection (Xgeva)

Administration Instructions for Denosumab Injection

Denosumab is administered as a subcutaneous injection, meaning it is injected under the skin. It is typically given by a healthcare professional, but in some cases, patients may be trained to administer the injection themselves at home. Follow your healthcare provider’s instructions carefully. If you miss a dose, contact your provider as soon as possible to reschedule. Do not attempt to double up on doses without consulting your doctor.

Denosumab Side Effects and Adverse Reactions

Like all medications, Denosumab may cause side effects. Below are some potential side effects, categorized by how common they are:

1. Common: Back pain, muscle pain, joint pain, high cholesterol, and urinary tract infections.
2. Less Common: Skin infections, low calcium levels (hypocalcemia), and jaw bone problems (osteonecrosis of the jaw).
3. Rare but Serious: Severe allergic reactions, unusual thigh bone fractures, and delayed healing of broken bones.

If you experience any severe or unusual symptoms, contact your healthcare provider immediately. If you’re concerned about side effects, our telemedicine providers are available to discuss your treatment options.

Contraindications for Denosumab Treatment

A contraindication is a specific situation or condition in which a medication should not be used because it may cause harm to the patient. For Denosumab, there are several contraindications that your healthcare provider will consider before prescribing it.

1. Hypocalcemia (Low Calcium Levels): Denosumab can further lower calcium levels in your blood. If you already have low calcium, taking Denosumab can lead to serious complications, such as muscle spasms, heart problems, or seizures.
2. Allergic Reactions to Denosumab: If you have had an allergic reaction to Denosumab or any of its ingredients in the past, you should not take this medication. Allergic reactions can range from mild skin rashes to severe, life-threatening conditions like anaphylaxis.
3. Pregnancy: Denosumab is not recommended for use during pregnancy because it may harm the developing fetus. More details are provided in the pregnancy section below.
4. Severe Kidney Disease: Patients with severe kidney disease or those on dialysis may be at higher risk for developing low calcium levels when taking Denosumab. Your doctor will need to monitor your calcium levels closely if you have kidney problems.
5. Osteonecrosis of the Jaw (ONJ): If you have a history of ONJ, a condition where the jawbone begins to die, Denosumab may increase the risk of worsening this condition. Your healthcare provider will evaluate your dental health before prescribing this medication.

Drug-to-Drug Interactions with Denosumab

Denosumab can interact with other medications, which may increase the risk of side effects or reduce the effectiveness of your treatment. Be sure to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs and supplements. Some of the medications that may interact with Denosumab include:

1. Bisphosphonates (e.g., Alendronate [Fosamax], Ibandronate [Boniva]): These medications are also used to treat osteoporosis and may increase the risk of side effects when taken with Denosumab.
2. Immunosuppressants (e.g., Methotrexate, Cyclosporine): These medications can weaken the immune system, and when combined with Denosumab, they may increase the risk of infections.
3. Corticosteroids (e.g., Prednisone): Long-term use of corticosteroids can increase the risk of bone loss, and taking them with Denosumab may require additional monitoring of bone health.
4. Calcium Supplements and Vitamin D: While these are not necessarily harmful, it is important to take them as directed by your healthcare provider to avoid complications such as high calcium levels or other imbalances.

Denosumab in Pregnancy

Is it safe to take Denosumab when pregnant?

Denosumab is generally not recommended during pregnancy. Animal studies have shown that it may harm a developing fetus, and there is limited information on its effects in pregnant women. If you are pregnant or planning to become pregnant, it’s important to discuss alternative treatment options with your healthcare provider. Should you become pregnant while taking Denosumab, contact your doctor immediately to determine the safest course of action.

Denosumab while Breastfeeding

Is it safe to take Denosumab while breastfeeding?

It is currently unclear whether Denosumab passes into breast milk. Due to the potential risk of serious side effects in nursing infants, breastfeeding is not recommended while taking this medication. If you are breastfeeding or planning to breastfeed, consult your healthcare provider to explore alternative treatments or discuss whether it may be necessary to stop breastfeeding while on Denosumab.

Estimated Cost of Denosumab Treatment

The cost of Denosumab can vary depending on your location and insurance coverage. Without insurance, the estimated price for a 30-day supply, using a GoodRX coupon, ranges from $1,200 to $1,500. For the most accurate pricing, check with your pharmacy, and if you have concerns about the cost, speak with your healthcare provider about potential financial assistance or alternative options.

Possible Alternatives to Denosumab

If Denosumab is not suitable for you, or if you are considering other options, several alternatives are available. Always consult your healthcare provider before making any changes to your treatment plan. You can also schedule a telemedicine appointment with one of our providers to discuss these alternatives in more detail.

Osteoporosis

Alternatives include bisphosphonates (such as Alendronate or Risedronate), hormone replacement therapy, or lifestyle modifications like increasing calcium and vitamin D intake, engaging in weight-bearing exercises, and quitting smoking.

Bone Metastases

Other treatment options may include bisphosphonates (such as Zoledronic acid) or radiation therapy. Pain management and physical therapy can also play a role in improving quality of life.

Giant Cell Tumor of Bone

Surgery is typically the first-line treatment. In some cases, radiation therapy or medications like interferon may also be considered.

Hypercalcemia of Malignancy

Bisphosphonates (such as Pamidronate) or calcitonin may help lower elevated calcium levels. Hydration and diuretics can also assist in managing this condition.

Paget’s Disease of Bone

Bisphosphonates are the most commonly used alternative treatment. Physical therapy and pain management strategies may also provide relief.

Multiple Myeloma

Treatment options include chemotherapy, targeted therapies, and stem cell transplants. Bisphosphonates may also be used to manage bone-related complications.

Osteogenesis Imperfecta

Common treatments include physical therapy, surgery, and bisphosphonates. Maintaining a healthy lifestyle with proper nutrition and regular exercise is also important for managing this condition.

Osteopenia

Lifestyle changes, such as increasing calcium and vitamin D intake, engaging in regular exercise, and avoiding smoking and excessive alcohol consumption, can help manage osteopenia. Medications like bisphosphonates may also be considered.

Rheumatoid Arthritis

Disease-modifying antirheumatic drugs (DMARDs), such as Methotrexate, or biologics like Adalimumab (Humira), are commonly used treatments. Physical therapy and lifestyle changes, including regular exercise and a balanced diet, can also help manage symptoms.

Osteolytic Lesions

Treatment options may include radiation therapy, surgery, or medications like bisphosphonates or Denosumab. Pain management and physical therapy can also be beneficial.

Recent Updates on Denosumab Research

Recent studies have focused on the long-term safety and effectiveness of Denosumab, particularly in treating osteoporosis and bone metastases. One area of ongoing research is Denosumab’s potential to reduce fracture risk in osteoporosis patients over extended periods. Researchers are also exploring its use in other bone-related conditions, such as osteogenesis imperfecta and multiple myeloma. Additionally, some studies are investigating the risk of osteonecrosis of the jaw (ONJ) and strategies to minimize this risk in patients receiving long-term Denosumab treatment. Stay informed about the latest research and discuss any concerns with your healthcare provider.

James Kingsley

Learn More